ASTRAZENECA PHARMA INDIA LTD. - 506820 - Outcome Of The Board Meeting Held On Monday, February 8, 2021

AstraZeneca Pharma India Ltd.

NSE: ASTRAZEN | BSE: 506820 | ISIN: INE203A01020 |Industry: Pharmaceuticals
|Expensive Performer

3590.75 135.05 (3.91%)

NSE Apr 19, 2021 16:00 PM

27.75% Fall from 52W High

Volume: 222.0K

High volume today

AstraZeneca Pharma India Ltd.

08 Feb 2021

3590.75

3.91%

Result

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Outcome Of The Board Meeting Held On Monday, February ...

BSE India

At the Board meeting of the Company held on Monday, February 8, 2021 the Board of Directors considered and approved the Unaudited Financial Results of the Company for the quarter ended December 31, 2020. The said Unaudited Financial Results together with the Limited Review report of the Statutory Auditors dated February 8, 2021 are enclosed herewith.

Recommended

AstraZeneca likely to have COVID-19 vaccine against South African variant by 2021-end

Business Today | 19 Apr 2021, 08:19AM

Australia reports first fatality from blood clots 'likely' linked to AstraZeneca COVID-19 vaccine

Business Today | 16 Apr 2021

AstraZeneca Pharma India Ltd - 506820 - Statement Of Investor Complaints For The Quarter Ended March 2021

BSE India | 16 Apr 2021

More from AstraZeneca Pharma India Ltd.

HDFC Bank Ltd.: HDFC Bank working on Technology Transformation Agenda
Business Line| 13 updates

MindTree Ltd.: Brokerages see up to 14% upside in Mindtree shares
livemint| 5 updates

Future Retail Ltd.: Future Retail gets lenders' nod to restructure debt
Business Line| 4 updates

Macrotech Developers..: Macrotech Developers share tanks 13% on debut: What should investors do?
Moneycontrol| 3 updates

Infosys Ltd.: Infosys COO asks all staff to work from home, get vaccinated if eligible
Business Standard| 3 updates

See all Indices

See all Sectoral Indices

Superstar Portfolios

Individuals
Institutions

Name	Companies Held
Hitesh Ramji Javeri	50
Mahendra Girdharilal	50
Sangeetha S	50
Mukul Agrawal	44
Dheeraj Kumar Lohia	42

Name	Companies Held
Hdfc Trustee Company Limited	93
Birla Sun Life Trustee Com...	55
President Of India	52
General Insurance Corporat...	50
Government Pension Fund Gl...	50

See how Results season is
panning out

Go to Latest Results Dashboard

11

Positive Results

2

Negative results

0

Neutral results

8.2%

Total Revenue Growth

10.0%

Total EBIDT growth

20.9%

Total Oper. Profit growth

BEST EQUITY MUTUAL FUNDS

Name	Returns(%)
Name	Week	Month	Year
Quant Active Fund - Reg - G	-1.04%	5.92%	102.54%
UTI - Equity Fund. - Reg - G	-2.31%	-1.43%	74.23%
Quant Focused Fund - Reg - G	-1.17%	4.22%	71.95%
UTI - Core Equity Fund - Reg - G	-1.93%	-2.17%	69.53%
HDFC Growth Opportunities Fund - Reg - G	-2.33%	-3.02%	66.08%

See all Large Cap funds

Name	Returns(%)
Name	Week	Month	Year
Kotak Small Cap Fund - Reg - G	-2.66%	-0.38%	115.32%
IDFC STERLING VALUE FUND - Reg - G	-2.69%	0.02%	101.72%
Reliance Small Cap Fund - Reg - G	-2.72%	-0.85%	100.50%
DHFL Pramerica Midcap Opportunities Fund - Reg - G	-3.08%	-0.47%	98.80%
Aditya Birla Sun Life Small Cap Fund - Reg - G	-3.60%	-1.77%	93.45%

See all Small & Mid Cap funds

Name	Returns(%)
Name	Week	Month	Year
ICICI Prudential Smallcap Fund - Reg - G	-3.53%	-2.99%	94.18%
HDFC Small Cap Fund - Reg - G	-2.33%	0.41%	92.72%
DHFL Pramerica Diversified Equity Fund - Reg - G	-2.13%	0.44%	82.52%
Quant Mid Cap Fund - Reg - G	-3.17%	4.82%	78.99%
Templeton India Value Fund (erstwhile known as Templeton India Growth Fund) - Reg - G	-1.98%	-4.74%	78.82%

See all Diversified Equity funds

See all Indices

See all Sectoral Indices